摘要
热休克蛋白 (HSPs) 作为蛋白质稳定的分子伴侣发挥着重要作用。小 HSP 是一组 12-43 kDa 范围内的低分子量 HSP,被归类为 HSPB。在该家族的十个成员中,HSPB1(HSP27)、HSPB5(αB-晶状体蛋白)、HSPB6(HSP20)和 HSPB8(HSP22)普遍存在于各种组织中,包括肝组织。这些小的 HSP 作为翻译后修饰进行磷酸化,并且它们的功能受到调节。肝细胞癌(HCC)是最常见的癌症之一,也是全球癌症相关死亡的第四大原因。 HSP作为分子伴侣发挥细胞保护作用。因此,HSPB通常被认为可以保护HCC细胞并帮助HCC的进展。另一方面,我们实验室最近的研究表明磷酸化 HSPB1、HSPB6 和 HSPB8 在 HCC 进展中的抑制作用。这些发现可能为 HSPB 针对 HCC 进展的新型防御系统提供基础。本综述重点关注 HSPB 在 HCC 中的细胞功能并总结了目前的研究。
关键词: 小HSP、HSPB、HCC、细胞凋亡、增殖、转移。
Current Molecular Medicine
Title:Cellular Functions of Small Heat Shock Proteins (HSPB) in Hepatocellular Carcinoma
Volume: 21 Issue: 10
关键词: 小HSP、HSPB、HCC、细胞凋亡、增殖、转移。
摘要: Heat shock proteins (HSPs) play an essential role as molecular chaperones in proteostasis. Small HSPs are a group of low-molecular-weight HSPs in the range of 12- 43 kDa and are classified as HSPB. Within the ten members of the family, HSPB1(HSP27), HSPB5 (αB-crystallin), HSPB6 (HSP20), and HSPB8 (HSP22) ubiquitously exist in various tissues, including liver tissue. These small HSPs undergo phosphorylation as a post-translational modification, and their functions are modulated. Hepatocellular carcinoma (HCC) is one of the most frequent cancers and the fourth leading cause of cancer-related death worldwide. HSPs play a cytoprotective role as molecular chaperones. Thus, HSPB has been generally considered to protect HCC cells and help the progression of HCC. On the other hand, recent studies from our laboratories have demonstrated suppressive roles of phospho-HSPB1, HSPB6, and HSPB8 in the progression of HCC. These findings may provide a basis for a novel defense system by HSPB against HCC progression. This review focuses on the cellular functions of HSPB in HCC and summarizes the current research.
Export Options
About this article
Cite this article as:
Cellular Functions of Small Heat Shock Proteins (HSPB) in Hepatocellular Carcinoma, Current Molecular Medicine 2021; 21 (10) . https://dx.doi.org/10.2174/1573405617666210204211252
DOI https://dx.doi.org/10.2174/1573405617666210204211252 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
From Nanotechnology to Nanomedicine: Applications to Cancer Research
Current Molecular Medicine Gallium-68 in Medical Imaging
Current Radiopharmaceuticals Therapeutic Implications of Superoxide Dismutase And Its Importance in Kinase Drug Discovery
Current Topics in Medicinal Chemistry DNA Repair Proteins as Molecular Targets for Cancer Therapeutics
Anti-Cancer Agents in Medicinal Chemistry Spirolactones: Recent Advances in Natural Products, Bioactive Compounds and Synthetic Strategies
Current Medicinal Chemistry Enhanced Intracellular Delivery of Curcumin by Chitosan-Lipoic Acid as Reduction-Responsive Nanoparticles
Current Pharmaceutical Biotechnology Targeted Drugs and Nanomedicine: Present and Future
Current Pharmaceutical Design Reactive Oxygen Species: Physiological Roles in the Regulation of Vascular Cells
Current Molecular Medicine Recent Progress in the Functionalization of Benzo-γ-Pyrones via Transition- Metal Catalyzed Cross-Coupling Reactions
Mini-Reviews in Organic Chemistry Castration-resistant Prostate Cancer: Novel Therapeutics Pre- or Post- Taxane Administration
Current Cancer Drug Targets Influence of the Bystander Effect on HSV-tk / GCV Gene Therapy. A Review.
Current Gene Therapy Exosomes: A Role for Naturally Occurring Nanovesicles in Cancer Growth, Diagnosis and Treatment
Current Gene Therapy Targeting Endothelial Progenitor Cells in Cancer as a Novel Biomarker and Anti-Angiogenic Therapy
Current Stem Cell Research & Therapy Antioxidant Nanoplatforms for Dermal Delivery: Melatonin
Current Drug Metabolism Old Tyrosine Kinase Inhibitors and Newcomers in Gastrointestinal Cancer Treatment
Current Cancer Drug Targets Novel HSP90 Inhibitor NVP-AUY922 Enhances the Anti-tumor Effect of Temsirolimus Against Oral Squamous Cell Carcinoma
Current Cancer Drug Targets Protective Potential of Uric Acid, Folic Acid, Glutathione and Ascorbic Acid Against the Formation of Toxic Met-Myoglobin
Protein & Peptide Letters A Prooxidant Mechanism for the Anticancer and Chemopreventive Properties of Plant Polyphenols
Current Drug Targets Engineered Nanoparticles in Cancer Therapy
Recent Patents on Drug Delivery & Formulation Immunotherapy in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck
Anti-Cancer Agents in Medicinal Chemistry